Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7512215PMC
http://dx.doi.org/10.1186/s13054-020-03293-8DOI Listing

Publication Analysis

Top Keywords

fibrin-derived peptide
4
peptide bβ15-42
4
bβ15-42 fx06
4
fx06 salvage
4
salvage treatment
4
treatment critically
4
critically ill
4
ill patients
4
patients covid-19-associated
4
covid-19-associated acute
4

Similar Publications

Background: Fibrin(ogen) deposition in the central nervous system (CNS) contributes to neuropathological injury; however, its role in ischemic stroke is unknown. In this study, we identified fibrinogen as a novel proinflammatory regulator of post-stroke neuroinflammation and revealed the neuro-protection effect of fibrin-derived γpeptide in stroke.

Methods: Fibrinogen depletion and fibrinogen-derived γpeptide treatment were performed 2 h after establishing a permanent middle cerebral artery occlusion (pMCAO) model.

View Article and Find Full Text PDF

Increased vascular permeability is a prevalent feature in a wide spectrum of clinical conditions, but no effective treatments to restore the endothelial barrier are available. Idiopathic systemic capillary leak syndrome (ISCLS) is a life-threatening Paroxysmal Permeability Disorder characterized by abrupt, massive plasma extravasation. This condition serves as a robust model for investigating therapeutic approaches targeting interendothelial junctions.

View Article and Find Full Text PDF

Background: In rheumatoid arthritis (RA), antibodies to citrullinated protein (ACPA) are believed to be heterogeneous and patient stratification by antibody profiling raised clinical interest for patient management. However, heterogeneity might be partially artificial because of the use of heterogeneous methods for ACPA detection. In recent work instead, we found that ACPA were mainly directed towards a single fibrin-derived peptide, β60-74BiotNt, but a comparative analysis with the presence of other ACPA specificities is still lacking.

View Article and Find Full Text PDF

Lassa hemorrhagic shock syndrome-on-a-chip.

Biotechnol Bioeng

March 2021

Medical Systems Biophysics and Bioengineering, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.

Lack of experimental human models hinders research on Lassa hemorrhagic fever and the development of treatment strategies. Here, we report the first chip-based model for Lassa hemorrhagic syndrome. The chip features a microvessel interfacing collagen network as a simple mimic for extracellular matrix, allowing for quantitative and real-time vascular integrity assessment.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!